UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.84 +0.82 (+1.05%) GOLD FUTURES
2,389.80 +29.90 (+1.27%) DOW
39,888.19 +330.08 (+0.83%) Bitcoin GBP
52,255.24 +3,685.80 (+7.59%)
Pfizer Inc (PFE.HM)
Hamburg - Hamburg Delayed price. Currency in EUR
Add to watchlist
As of 05:21PM CEST. Market open.
| Previous close | 26.33 |
| Open | 26.22 |
| Bid | 26.48 x 0 |
| Ask | 26.50 x 0 |
| Day's range | 26.22 - 26.43 |
| 52-week range | 23.64 - 37.35 |
| Volume | |
| Avg. volume | 621 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
BenzingaPfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Pfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform under the brand “Pfizer for All.” The move, reflected in a recent trademark application, aims to provide medical information, mail-order pharmacy, and telehealth services to US patients. Recent reports indicate Pfizer’s intention to include various medications, including its COVID antiviral Paxlovid and diagnostic kits, on the platform later this year, e
Yahoo FinanceOne stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
ZacksModerna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Moderna's (MRNA) RSV vaccine, mRNA-1345's review timeline gets delayed. A decision is now expected by the end of May.
© 2024 Yahoo. All rights reserved.